19 reports

Hematopoietic Stem Cell Transplantation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019 ##.

  • General Medicine And Specialty Medicine
  • Stem Cell Transplant
  • Transplantation
  • Demand
  • Product Initiative

Transplant type segment of HSCT market was divided into autologous transplant and allogeneic transplant.

  • Stem Cell Transplant
  • APAC
  • World
  • Forecast
  • Market Size
  • TOP COMPANIES PARTICIPATING IN STEM CELL TRANSPLANTATION THERAPEUTICS CLINICAL TRIALS
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF STEM CELL TRANSPLANTATION TO IMMUNOLOGY CLINICAL TRIALS

Stem Cell Transplantation Global Clinical Trials Review, H##, 2019 H e a l t h c a r e H e a l t h c a r e Reference Code: GDHC##CTIDB Publication Date: OCT 2019 LIST OF TABLES LIST OF FIGURES Stem Cell Transplantation Global Clinical Trials Rev

  • Drug Development
  • General Medicine And Specialty Medicine
  • Stem Cell Transplant
  • World
  • Product Initiative

Some of the prominent trends that the market is witnessing include technological advancements in regenerative stromal cell therapy, development of transplantation activity across the globe, recent technological developments of Hematopoietic Stem Cell Transplantation and growth oppo

  • Stem Cell Transplant
  • APAC
  • World
  • Forecast
  • Market Size

2019 Stem Cell Transplantation Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Stem Cell Transplant
  • Transplantation
  • APAC

ReNeuron Group Plc (UK) ##.

  • Stem Cell Transplant
  • Europe
  • United States
  • World
  • Market Shares

(USA) ##.

  • Stem Cell Transplant
  • Europe
  • United States
  • World
  • Market Shares

(USA) ##.

  • Stem Cell Transplant
  • Europe
  • United States
  • World
  • Market Shares

(USA) ##.

  • Stem Cell Transplant
  • Europe
  • United States
  • World
  • Market Shares

COMPANY SNIPPETS.............. ## ##.

  • General Medicine And Specialty Medicine
  • Stem Cell Transplant
  • China
  • United States
  • Market Shares

(USA) ##.

  • Stem Cell Transplant
  • Therapy
  • United States
  • World
  • Market Shares
  • Mar 30, 2016: FDA approves first treatment for rare disease in patients who receive stem cell transplant from blood or bone marrow
  • Aug 02, 2016: CMS Grants New Technology Add-On Payment to Defitelio for the Treatment of Hepatic Veno- Occlusive Disease with Renal or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation

The company said, ## patients had undergone stem cell transplant (SCT) and the remaining ## had developed VOD after chemotherapy alone.

  • Pharmaceutical
  • Stem Cell Transplant
  • Therapy
  • United States
  • Product Initiative

Key Findings ##.

  • General Medicine And Specialty Medicine
  • Stem Cell Transplant
  • Transplantation
  • World
  • Clinical Trial profile. 99 Trial Title
  • Clinical Trial profile. 213 Trial Title

These are very encouraging early outcome results for children who need a stem cell transplant and lack a matched donor. "

  • Blood Disease
  • Medical Biotechnology
  • Stem Cell Transplant
  • World
  • Product Initiative

Hematopoietic Stem Cell Transplantation - Pipeline Insight, 2019 ##.

  • General Medicine And Specialty Medicine
  • Stem Cell Transplant
  • Transplantation

2019 Hematopoietic Stem Cell Transplantation Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ##.

  • Cell Therapy
  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Stem Cell Transplant
  • Transplantation

2019 Hematopoietic Stem Cell Transplantation Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Stem Cell Transplant
  • Transplantation
  • APAC

GVHD is a serious, life-threating complication of stem cell transplantation, affecting over ##% of all patients undergoing allogeneic stem cell transplantation.

  • Pharmaceutical
  • Stem Cell Transplant
  • United States
  • Product Initiative
  • Athersys, Inc.
  • ACTIMAB-B - DRUG PROFILE

GVHD is a serious, life-threatening complication of stem cell transplantation, affecting over ##% of all patients undergoing allogeneic stem cell transplantation.

  • Cell Therapy
  • Stem Cell Transplant
  • Therapy
  • Transplantation
  • Athersys, Inc.